HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle.

Abstract
Interferons (IFNs) are the first line of defense against viral infections. Although type I and II IFNs have proven effective to inhibit foot-and-mouth disease virus (FMDV) replication in swine, a similar approach had only limited efficacy in cattle. Recently, a new family of IFNs, type III IFN or IFN-λ, has been identified in human, mouse, chicken, and swine. We have identified bovine IFN-λ3 (boIFN-λ3), also known as interleukin 28B (IL-28B), and demonstrated that expression of this molecule using a recombinant replication-defective human adenovirus type 5 (Ad5) vector, Ad5-boIFN-λ3, exhibited antiviral activity against FMDV in bovine cell culture. Furthermore, inoculation of cattle with Ad5-boIFN-λ3 induced systemic antiviral activity and upregulation of IFN-stimulated gene expression in the upper respiratory airways and skin. In the present study, we demonstrated that disease could be delayed for at least 6 days when cattle were inoculated with Ad5-boIFN-λ3 and challenged 24 h later by intradermolingual inoculation with FMDV. Furthermore, the delay in the appearance of disease was significantly prolonged when treated cattle were challenged by aerosolization of FMDV, using a method that resembles the natural route of infection. No clinical signs of FMD, viremia, or viral shedding in nasal swabs was found in the Ad5-boIFN-λ3-treated animals for at least 9 days postchallenge. Our results indicate that boIFN-λ3 plays a critical role in the innate immune response of cattle against FMDV. To this end, this work represents the most successful biotherapeutic strategy so far tested to control FMDV in cattle.
AuthorsEva Perez-Martin, Marcelo Weiss, Fayna Diaz-San Segundo, Juan M Pacheco, Jonathan Arzt, Marvin J Grubman, Teresa de los Santos
JournalJournal of virology (J Virol) Vol. 86 Issue 8 Pg. 4477-87 (Apr 2012) ISSN: 1098-5514 [Electronic] United States
PMID22301155 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Antiviral Agents
  • Interferon-gamma
Topics
  • Animals
  • Antibodies, Neutralizing (blood, immunology)
  • Antibodies, Viral (blood, immunology)
  • Antiviral Agents
  • Cattle
  • Cattle Diseases (immunology, therapy)
  • Cell Line
  • Cricetinae
  • Foot-and-Mouth Disease (genetics, immunology, therapy)
  • Foot-and-Mouth Disease Virus (immunology)
  • Gene Expression Profiling
  • Gene Expression Regulation
  • Humans
  • Interferon-gamma (genetics)
  • Leukocytes, Mononuclear (metabolism)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: